Furthermore, the increased expression and activity of EPHX2 results in decreased EET levels and thus the EPHX2/EET pathway contributes to obesity and diabetes-induced endothelial dysfunction and cardiovascular disease [7]. This evidence concerns the gene EPHX2 and obesity due to melanocortin 4 receptor deficiency.